Literature DB >> 29476165

Genetics of dementia in a Finnish cohort.

Petra Pasanen1,2, Liisa Myllykangas3, Minna Pöyhönen4,5, Anna Kiviharju6, Maija Siitonen7, John Hardy8, Jose Bras8,9,10, Anders Paetau3, Pentti J Tienari6,11, Rita Guerreiro8,9,10, Auli Verkkoniemi-Ahola11.   

Abstract

Alzheimer's disease (AD) and frontotemporal dementia (FTD) are the two most common neurodegenerative dementias. Variants in APP, PSEN1 and PSEN2 are typically linked to early-onset AD, and several genetic risk loci are associated with late-onset AD. Inherited FTD can be caused by hexanucleotide expansions in C9orf72, or variants in GRN, MAPT or CHMP2B. Several other genes have also been linked to FTD or FTD with motor neuron disease. Here we describe a cohort of 60 Finnish families with possible inherited dementia. Our aim was to clarify the genetic background of dementia in this cohort by analysing both known dementia-associated genes (APOE, APP, C9ORF72, GRN, PSEN1 and PSEN2) and searching for rare or novel segregating variants with exome sequencing. C9orf72 repeat expansions were detected in 12 (20%) of the 60 families, including, in addition to FTD, a family with neuropathologically verified AD. Twelve families (10 with AD and 2 with FTD) with representative samples from affected and unaffected subjects and without C9orf72 expansions were selected for whole-exome sequencing. Exome sequencing did not reveal any variants that could be regarded unequivocally causative, but revealed potentially damaging variants in UNC13C and MARCH4.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29476165      PMCID: PMC5974394          DOI: 10.1038/s41431-018-0117-3

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  66 in total

1.  Alzheimer disease PS-1 exon 9 deletion defined.

Authors:  G Prihar; A Verkkoniem; J Perez-Tur; R Crook; S Lincoln; H Houlden; M Somer; A Paetau; H Kalimo; A Grover; L Myllykangas; M Hutton; J Hardy; M Haltia
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

Review 2.  Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond.

Authors:  Elise Cuyvers; Kristel Sleegers
Journal:  Lancet Neurol       Date:  2016-07       Impact factor: 44.182

3.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Authors:  Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

4.  C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment.

Authors:  Rita Cacace; Caroline Van Cauwenberghe; Karolien Bettens; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Mathieu Vandenbulcke; Jasper Van Dongen; Veerle Bäumer; Lubina Dillen; Maria Mattheijssens; Karin Peeters; Marc Cruts; Rik Vandenberghe; Peter P De Deyn; Christine Van Broeckhoven; Kristel Sleegers
Journal:  Neurobiol Aging       Date:  2013-01-24       Impact factor: 4.673

5.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.

Authors:  Minerva M Carrasquillo; Fanggeng Zou; V Shane Pankratz; Samantha L Wilcox; Li Ma; Louise P Walker; Samuel G Younkin; Curtis S Younkin; Linda H Younkin; Gina D Bisceglio; Nilufer Ertekin-Taner; Julia E Crook; Dennis W Dickson; Ronald C Petersen; Neill R Graff-Radford; Steven G Younkin
Journal:  Nat Genet       Date:  2009-01-11       Impact factor: 38.330

6.  Repeat expansion in C9ORF72 in Alzheimer's disease.

Authors:  Elisa Majounie; Yevgeniya Abramzon; Alan E Renton; Rodney Perry; Susan S Bassett; Olga Pletnikova; Juan C Troncoso; John Hardy; Andrew B Singleton; Bryan J Traynor
Journal:  N Engl J Med       Date:  2012-01-04       Impact factor: 91.245

7.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

8.  SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis.

Authors:  Isabelle Le Ber; Agnès Camuzat; Rita Guerreiro; Kawtar Bouya-Ahmed; Jose Bras; Gael Nicolas; Audrey Gabelle; Mira Didic; Anne De Septenville; Stéphanie Millecamps; Timothée Lenglet; Morwena Latouche; Edor Kabashi; Dominique Campion; Didier Hannequin; John Hardy; Alexis Brice
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

9.  Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk.

Authors:  Karolien Bettens; Nathalie Brouwers; Sebastiaan Engelborghs; Jean-Charles Lambert; Ekaterina Rogaeva; Rik Vandenberghe; Nathalie Le Bastard; Florence Pasquier; Steven Vermeulen; Jasper Van Dongen; Maria Mattheijssens; Karin Peeters; Richard Mayeux; Peter St George-Hyslop; Philippe Amouyel; Peter P De Deyn; Kristel Sleegers; Christine Van Broeckhoven
Journal:  Mol Neurodegener       Date:  2012-01-16       Impact factor: 14.195

10.  CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Kelly L Williams; Simon Topp; Shu Yang; Bradley Smith; Jennifer A Fifita; Sadaf T Warraich; Katharine Y Zhang; Natalie Farrawell; Caroline Vance; Xun Hu; Alessandra Chesi; Claire S Leblond; Albert Lee; Stephanie L Rayner; Vinod Sundaramoorthy; Carol Dobson-Stone; Mark P Molloy; Marka van Blitterswijk; Dennis W Dickson; Ronald C Petersen; Neill R Graff-Radford; Bradley F Boeve; Melissa E Murray; Cyril Pottier; Emily Don; Claire Winnick; Emily P McCann; Alison Hogan; Hussein Daoud; Annie Levert; Patrick A Dion; Jun Mitsui; Hiroyuki Ishiura; Yuji Takahashi; Jun Goto; Jason Kost; Cinzia Gellera; Athina Soragia Gkazi; Jack Miller; Joanne Stockton; William S Brooks; Karyn Boundy; Meraida Polak; José Luis Muñoz-Blanco; Jesús Esteban-Pérez; Alberto Rábano; Orla Hardiman; Karen E Morrison; Nicola Ticozzi; Vincenzo Silani; Jacqueline de Belleroche; Jonathan D Glass; John B J Kwok; Gilles J Guillemin; Roger S Chung; Shoji Tsuji; Robert H Brown; Alberto García-Redondo; Rosa Rademakers; John E Landers; Aaron D Gitler; Guy A Rouleau; Nicholas J Cole; Justin J Yerbury; Julie D Atkin; Christopher E Shaw; Garth A Nicholson; Ian P Blair
Journal:  Nat Commun       Date:  2016-04-15       Impact factor: 17.694

View more
  1 in total

1.  Longevity-related molecular pathways are subject to midlife "switch" in humans.

Authors:  James A Timmons; Claude-Henry Volmar; Hannah Crossland; Bethan E Phillips; Sanjana Sood; Karolina J Janczura; Timo Törmäkangas; Urho M Kujala; William E Kraus; Philip J Atherton; Claes Wahlestedt
Journal:  Aging Cell       Date:  2019-06-06       Impact factor: 9.304

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.